RxDoctor Payments Data

Stefan Lampe-Strang, MD

Psychiatry · San Luis Obispo, CANPI 1366647463

Payments from drug & device makers

$381in general payments, 2019–2025

Across 16 payments — averaging $23.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$151
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$94
  • E.r. Squibb & Sons, L.L.C.$45
  • Alkermes, Inc.$21
  • AbbVie$19
  • Indivior Inc.$19
  • plus $33 from 2 others

What the payments were for

  • Food & beverage$30179%
  • Education$8021%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$381 in reported general payments places this provider in the 60th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$14,748
Medicare patients
15
Services billed
111

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate102$345,849
LybalviOlanzapine/Samidorphan Malate36$70,263
CaplytaLumateperone Tosylate30$49,378
VivitrolNaltrexone Microspheres14$23,542
OzempicSemaglutide15$15,038
TrintellixVortioxetine Hydrobromide14$7,037
Pregabalin45$917
Bupropion XlBupropion Hcl29$796
Divalproex Sodium ErDivalproex Sodium18$427
Lithium Carbonate ErLithium Carbonate18$422
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide22$407
Gabapentin22$336
Buspirone Hcl14$293
Quetiapine Fumarate13$254
Olanzapine17$238

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Lybalvi, Vivitrol$21$93,80550 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$94$49,37830 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,954 psychiatry providers in California.

Other psychiatry in San Luis Obispo

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →